ClinicalTrials.gg
Not yet recruitingNCT07753278Updated Aug 7, 2026

Fresh Gas Flow and Lung Ultrasonography in Laparoscopic Cholecystectomy

An interventional study of Low Fresh Gas Flow (0.5 L/min) and High Fresh Gas Flow (4 L/min) in Postoperative Atelectasis and Pulmonary Atelectasis, sponsored by Adiyaman University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Adiyaman University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective randomized clinical trial aims to evaluate the effects of different fresh gas flow rates on postoperative pulmonary aeration using lung ultrasonography in patients undergoing elective laparoscopic cholecystectomy. Patients will be randomly assigned to receive either low-flow anesthesia (0.5 L/min) or high-flow anesthesia (4 L/min) during maintenance of general anesthesia. The primary objective is to compare postoperative lung ultrasound scores and the incidence of atelectasis between the two groups.

Read the detailed description

Pulmonary atelectasis is one of the most common postoperative pulmonary complications following general anesthesia. Fresh gas flow is an important component of inhalational anesthesia and may influence airway humidity, gas exchange, respiratory mechanics, and pulmonary physiology. Although low-flow anesthesia has recognized economic, environmental, and physiological advantages, the effect of different fresh gas flow rates on postoperative lung aeration has not been adequately investigated.

This prospective, randomized, parallel-group clinical trial will be conducted at Adıyaman University Training and Research Hospital. Adult patients scheduled for elective laparoscopic cholecystectomy under general anesthesia will be randomly allocated to either a low-flow group (0.5 L/min) or a high-flow group (4 L/min) after an initial fresh gas flow of 4 L/min for 8 minutes following endotracheal intubation. Standardized anesthesia management will be applied to all participants.

Postoperative lung ultrasonography will be performed 30 minutes after extubation in the post-anesthesia care unit. Lung Ultrasound Score (LUS) and the incidence of postoperative atelectasis will be compared between the study groups. The findings are expected to provide evidence regarding the effects of different fresh gas flow strategies on postoperative pulmonary outcomes and may contribute to optimizing intraoperative anesthesia management.

02

Conditions studied

  • Postoperative Atelectasis
  • Pulmonary Atelectasis

Browse trials for

Keywords

  • Fresh Gas Flow
  • Lung Ultrasound Score
  • Pulmonary Complications
03

In context

Pulmonary Atelectasis

377 studies on the registry are indexed under Pulmonary Atelectasis; 93 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 268 interventional studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

Adiyaman University is the lead sponsor of 31 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older.
  • (ASA) physical status I-II.
  • Scheduled for elective laparoscopic cholecystectomy under general anesthesia.
  • Able and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study.
  • History of chronic respiratory disease, including severe asthma, (COPD), or bronchiolitis.
  • History of alcohol or substance abuse.
  • Intraoperative airway or respiratory complications during endotracheal intubation or surgery.
  • Life-threatening postoperative complications.
  • Patients with III or higher.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Low Fresh Gas Flow

    Participants will receive general anesthesia with a fresh gas flow rate of 0.5 L/min during the maintenance phase following an initial fresh gas flow of 4 L/min for 8 minutes after endotracheal intubation. Postoperative lung ultrasonography will be performed 30 minutes after extubation.

    Procedure: Low Fresh Gas Flow (0.5 L/min)

  • Active comparator
    High Fresh Gas Flow

    Participants will receive general anesthesia with a fresh gas flow rate of 4 L/min during the maintenance phase following an initial fresh gas flow of 4 L/min for 8 minutes after endotracheal intubation. Postoperative lung ultrasonography will be performed 30 minutes after extubation.

    Procedure: High Fresh Gas Flow (4 L/min)

Interventions

  • ProcedureLow Fresh Gas Flow (0.5 L/min)

    General anesthesia will be maintained using a fresh gas flow rate of 0.5 L/min after an initial fresh gas flow of 4 L/min for 8 minutes following endotracheal intubation.

  • ProcedureHigh Fresh Gas Flow (4 L/min)

    General anesthesia will be maintained using a fresh gas flow rate of 4 L/min after an initial fresh gas flow of 4 L/min for 8 minutes following endotracheal intubation.

06

What researchers measure

Primary outcomes

  1. Postoperative Lung Ultrasound Score

    Lung ultrasonography will be performed 30 minutes after extubation. Both lungs will be divided into 12 regions, with 6 regions assessed in each lung. Each region will be scored from 0 to 3: 0 indicates normal aeration with A-lines or fewer than three B-lines; 1 indicates at least three well-spaced B-lines; 2 indicates coalescent B-lines; and 3 indicates lung consolidation. The scores from all regions will be summed, resulting in a total score ranging from 0 to 36. Higher scores indicate greater loss of lung aeration.

    Time frame: 30 minutes after extubation

Secondary outcomes

  1. Incidence of postoperative atelectasis

    Atelectasis will be defined as a consolidation score ≥2 in any lung region assessed by lung ultrasonography

    Time frame: 30 minutes after extubation

  2. Peripheral oxygen saturation (SpO₂)

    Time frame: During surgery

  3. Mean arterial pressure

    Time frame: During surgery

  4. Heart rate

    Time frame: During surgery

  5. Peak airway pressure

    Peak airway pressure will be recorded during general anesthesia and compared between the low and high fresh gas flow groups.

    Time frame: Throughout the intraoperative period

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07753278
Lead sponsor
Adiyaman University
Responsible party
MEHMET DURAN (Assistant Professor, Adiyaman University) — Principal investigator
First posted
Aug 7, 2026
Start date
Aug 15, 2026 (estimated)
Primary completion
Oct 15, 2026 (estimated)
Completion
Oct 15, 2026 (estimated)
Last update
Aug 7, 2026

Study contacts

MEHMET DURAN, MD, Associate Professor
Contact
md021979@hotmail.com
+90 505 689 5404

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion